Literature DB >> 22796185

Molecular characteristics of extended-spectrum β-lactamase-producing Escherichia coli in Japan: emergence of CTX-M-15-producing E. coli ST131.

Hitoshi Kuroda1, Hisakazu Yano, Yoichi Hirakata, Kazuaki Arai, Shiro Endo, Hajime Kanamori, Hiromi Yamamoto, Sadahiro Ichimura, Miho Ogawa, Masahiro Shimojima, Mayumi Komatsu, Teruko Jonai, Sachiko Itagaki, Yuriko Nonomiya, Akira Suwabe, Mitsuo Kaku.   

Abstract

We investigated the molecular characteristics of ESBL-producing Escherichia coli in Japan. A total of 101 clinical isolates of ESBL-positive E. coli collected in Japan between June 2008 and November 2009 were studied. Among the 101 strains, 97 were positive for CTX-M, while 47 and two were positive for TEM and SHV, respectively. Sequencing revealed that CTX-M-14 was most common (49/101), followed by CTX-M-27 (22/101) and CTX-M-15 (8/101). Based on MLST data, seven of eight CTX-M-15 producers belonged to ST131. This is the first report about clinical isolates of E. coli ST131 possessing CTX-M-15 in Japan.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22796185     DOI： 10.1016/j.diagmicrobio.2012.06.011

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN： 0732-8893            Impact factor:   2.803


  7 in total

1.  JAID/JSC Guidelines for the Treatment of Respiratory Infectious Diseases: The Japanese Association for Infectious Diseases/Japanese Society of Chemotherapy - The JAID/JSC Guide to Clinical Management of Infectious Disease/Guideline-preparing Committee Respiratory Infectious Disease WG.

Authors:  Keiichi Mikasa; Nobuki Aoki; Yosuke Aoki; Shuichi Abe; Satoshi Iwata; Kazunobu Ouchi; Kei Kasahara; Junichi Kadota; Naoki Kishida; Osamu Kobayashi; Hiroshi Sakata; Masahumi Seki; Hiroki Tsukada; Yutaka Tokue; Fukumi Nakamura-Uchiyama; Futoshi Higa; Koichi Maeda; Katsunori Yanagihara; Koichiro Yoshida
Journal:  J Infect Chemother       Date:  2016-06-15       Impact factor: 2.211

Review 2.  Epidemic potential of Escherichia coli ST131 and Klebsiella pneumoniae ST258: a systematic review and meta-analysis.

Authors:  M J D Dautzenberg; M R Haverkate; M J M Bonten; M C J Bootsma
Journal:  BMJ Open       Date:  2016-03-17       Impact factor: 2.692

3.  Molecular characteristics of extended-spectrum β-lactamases in clinical isolates from Escherichia coli at a Japanese tertiary hospital.

Authors:  Hisakazu Yano; Mina Uemura; Shiro Endo; Hajime Kanamori; Shinya Inomata; Risako Kakuta; Sadahiro Ichimura; Miho Ogawa; Masahiro Shimojima; Noriomi Ishibashi; Tetsuji Aoyagi; Masumitsu Hatta; Yoshiaki Gu; Mitsuhiro Yamada; Koichi Tokuda; Hiroyuki Kunishima; Miho Kitagawa; Yoichi Hirakata; Mitsuo Kaku
Journal:  PLoS One       Date:  2013-05-15       Impact factor: 3.240

4.  CTX-M β-lactamase-producing Klebsiella pneumoniae in suburban New York City, New York, USA.

Authors:  Guiqing Wang; Tiangui Huang; Pavan Kumar Makam Surendraiah; Kemeng Wang; Rashida Komal; Jian Zhuge; Chian-Ru Chern; Alexander A Kryszuk; Cassidy King; Gary P Wormser
Journal:  Emerg Infect Dis       Date:  2013-11       Impact factor: 6.883

5.  To Use, or Not to Use Carbapenem When Extended-spectrum β-lactamase (ESBL)-producing Bacteria Are Isolated from Sputum Cultures, That Is the Question.

Authors:  Makoto Miki
Journal:  Intern Med       Date:  2017-12-21       Impact factor: 1.271

Review 6.  Extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae in cattle production - a threat around the world.

Authors:  Josman Dantas Palmeira; Helena Maria Neto Ferreira
Journal:  Heliyon       Date:  2020-01-30

7.  Change in the Antimicrobial Resistance Profile of Extended-Spectrum β-Lactamase-Producing Escherichia coli.

Authors:  Motoyasu Miyazaki; Yota Yamada; Koichi Matsuo; Yukie Komiya; Masanobu Uchiyama; Nobuhiko Nagata; Tohru Takata; Shiro Jimi; Osamu Imakyure
Journal:  J Clin Med Res       Date:  2019-09-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.